Authors: Faiza Shaik
Abstract: The use of nanorobotics in cancer therapy represents a groundbreaking evolution in the field of biomedical sciences, offering precision, efficiency, and adaptability in targeting malignant cells. These nanometer-scale devices are engineered to perform complex tasks at the cellular and molecular levels, enabling the direct delivery of anticancer agents to tumors while minimizing damage to healthy tissue. This paper explores the foundational principles of nanorobotics, their diverse types, and the technological advancements enabling their application in oncology. It delves into the mechanisms through which nanorobots navigate biological environments, recognize cancerous cells, and administer therapeutic agents with unmatched specificity. Additionally, the paper addresses the integration of sensors, actuators, and logic gates within nanorobots to enhance decision-making and responsiveness in real-time conditions. Challenges such as biocompatibility, immune response, power sources, and regulatory hurdles are discussed in detail. Furthermore, current experimental studies, clinical trials, and future perspectives in the development of nanorobotics for cancer therapy are critically analyzed. The convergence of nanotechnology, robotics, and medicine through nanorobotics holds the promise of redefining cancer treatment paradigms with higher survival rates and lower side effects.
DOI: http://doi.org/
